Väkevä A, Kontiainen S, Miettinen A, Schlenzka A, Mäenpää J
Department of Bacteriology and Immunology, University of Helsinki, Finland.
J Clin Pathol. 1992 Feb;45(2):106-9. doi: 10.1136/jcp.45.2.106.
To compare the prevalence of thyroid peroxidase antibodies in 25 children with autoimmune thyroid disorders and in 41 children and young adults with type 1 diabetes, and to test the prevalence of thyrotropin receptor antibodies.
Two commercially available radioimmunoassays for antibodies to thyroid peroxidase, a commercially available agglutination test of particles coated with thyroid microsomal antigens, and a radioimmunoassay for thyrotropin receptor antibodies were used. Patients and controls were studied.
One of the radioimmunoassays detected thyroid peroxidase antibodies not only in all children with autoimmune thyroid disorders and children and young adults with type 1 diabetes and thyroid microsomal antibodies, but also in 20% of healthy control children without microsomal antibodies. With this thyroid peroxidase assay and with microsomal agglutination, 94% of the children with autoimmune thyroiditis, 71% of those with Graves' disease, and over 90% of those with type 1 diabetes and thyroid dysfunction tested positive. In the other radioimmunoassay for thyroid peroxidase antibodies thyroid peroxidase antibody titres in half or more of the children with microsomal antibodies failed to reach the level of positivity given by the producers. Eighty five percent of children with Graves' disease and 71% of those with autoimmune thyroiditis had thyrotropin receptor antibodies but so did 35% of children studied for other endocrinological disorders such as delayed growth or puberty.
Testing patients with well characterised disorders of thyroid function and with other endocrine disorders is important in evaluating the efficacy of new diagnostic tests for thyroid autoantibodies.
比较25例自身免疫性甲状腺疾病患儿与41例1型糖尿病儿童及青年中甲状腺过氧化物酶抗体的患病率,并检测促甲状腺素受体抗体的患病率。
采用两种市售的甲状腺过氧化物酶抗体放射免疫测定法、一种市售的甲状腺微粒体抗原包被颗粒凝集试验以及一种促甲状腺素受体抗体放射免疫测定法。对患者和对照进行了研究。
其中一种放射免疫测定法不仅在所有自身免疫性甲状腺疾病患儿、1型糖尿病合并甲状腺微粒体抗体的儿童及青年中检测到甲状腺过氧化物酶抗体,还在20%无微粒体抗体的健康对照儿童中检测到。采用这种甲状腺过氧化物酶测定法和微粒体凝集试验,94%的自身免疫性甲状腺炎患儿、71%的格雷夫斯病患儿以及超过90%的1型糖尿病合并甲状腺功能障碍患儿检测呈阳性。在另一种甲状腺过氧化物酶抗体放射免疫测定法中,半数或半数以上有微粒体抗体的儿童甲状腺过氧化物酶抗体滴度未达到生产商给出的阳性水平。85%的格雷夫斯病患儿和71%的自身免疫性甲状腺炎患儿有促甲状腺素受体抗体,但在因生长发育迟缓或青春期延迟等其他内分泌疾病接受研究的儿童中,35%也有该抗体。
对甲状腺功能明确的疾病患者以及其他内分泌疾病患者进行检测,对于评估甲状腺自身抗体新诊断试验的疗效很重要。